Cytokine system

Mechanical Stretch and Cytokines

Volumn , Issue , 2012, Pages 1-33

  Simbirtsev, Andrey S ^a   Kozlov, Ivan G ^b,c  

^a State Scientific Institute of High Pure Biologicals   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c Oncology and Immunology   (Russian Federation)

Author keywords

Chemokines; Colony stimulating factors; Cytokine receptors; Cytokines; Growth factors; Interferons; Interleukins

Indexed keywords

EID: 84975689322     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-2004-6_1     Document Type: Chapter

References (172)

1. Aarvak T, Chabaud M, Miossec P, Natvig JB (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162:1246-1251
2. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3(9):745-756
3. Aggarwal BB, Natarajan K (1996) Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7:93-124
4. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA et al (1985) Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 260:2345-2354
5. Agnello D, Lankford CSR, Bream J et al (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23(3):147-161
6. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101(10):3765-3777
7. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL et al (1997) Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 94:9302-9307
8. Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787-820
9. Almeida A, Legrand N, Papiernik M et al (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169:4850-4860
10. Antonysamy MA, Thomson AW (1999) FLT3 ligand (FL) and its influence on immune reactivity. Cytokine 12:87-100
11. Appasamy PM (1992) IL 7-induced T cell receptor-gamma gene expression by pre-T cells in murine fetal liver cultures. J Immunol 149:1649-1656
12. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167-227
13. Arend WP (2003) The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13(4-5):323-340
14. Asadullah K, Sabat R, Friedrich M et al (2004) Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3(2):185-192
15. Aspinall R, Henson S, Pido-Lopez J, Ngom PT (2004) Interleukin-7: an interleukin for rejuvenating the immune system. Ann NY Acad Sci 1019:116-122
16. Bach EA, Aguet M, Schreiber RD (1997) The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-591
17. Bartlett NW, Buttigieg K, Kotenko SV, Smith GL (2005) Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J General Virol 86:1589-1596
18. Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87(18):6934-6938
19. Beadling C, Slifka MK (2006) Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp 54:15-24
20. Beebe AM, Cua DJ, de Waal Malefyt R (2003) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4-5):403-412
21. Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229(4716):869-871
22. Bhatia M, Davenport V, Cairo MS (2007) The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. Leuk Lymphoma 48(1):9-15
23. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V et al (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79-88
24. Bodmer JL, Schneider P, Tschopp J (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27:19-26
25. Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549-1555
26. Bonder CS, Finlay-Jones JJ, Hart PH (1999) Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain. Immunology 96:529-536
27. Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT et al (1988) The human interferon-beta 2/hepatocyte stimulating factor/interleukin-6 gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3:8-16
28. Bowie MB, Kent DG, Copley MR, Eaves CJ (2007) Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells. Blood 109(11):5043-5048
29. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD (1995) Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212-1218
30. Brombacher F, Kastelein RA, Alber G (2003) Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24:207-212
31. Brown MA, Hural J (1997) Functions of IL-4 and control of its expression. Crit Rev Immunol 17:1-32
32. Budagian V, Bulanova E, Orinska Z et al (2004) Reverse signaling through membrane-bound interleukin-15. J Biol Chem 279:42192-42201
33. Carswell EA, Old LJ, Fiore N, Schwartz MK (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
34. Chatila TA (2004) Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10(10):493-499
35. Chinnaiyan AM, O’Rourke K, Yu GL, Lyons RH, Garg M et al (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992
36. Cohen S, Bigazzi PE, Yoshida T (1974) Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 12:150-159
37. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T cell function. Nature 450:566-569
38. Colobran R, Pujol-Borrell R, Armengol MP, Juan M (2007) The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity. Clin Exp Immunol 148:208-217
39. Cooper M, Bush J, Fehniger T et al (2002) In vivo evidence for a dependence on interleukin-15 for natural killer cell survival. Blood 100:3633-3638
40. Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9(4):271-285
41. Curti A, Tafuri A, Ricciardi MR et al (2002) Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). Haematologica 87(4):373-380
42. Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago (2004) Cytokine 28:242-247
43. de Vries JE, Zurawski G (1995) Immunoregulatory properties of IL-13: its potential role in atopic disease. Int Arch Allergy Immunol 106(3):175-179
44. Debets R, Savelkoul HF (1994) Cytokine antagonists and their potential therapeutic use. Immunol Today 15(10):455-458
45. Dessein A, Kouriba B, Eboumbou C et al (2005) Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol Rev 201:180-190
46. Dinarello C (1996) Biological basis for interleukin-1 in disease. Blood 87:2095-2147
47. Dinarello CA (1998) Interleukin-1 beta, interleukin-18 and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 856:1-11
48. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
49. Dinarello CA, Wolff SM (1982) Molecular basis of fever in humans. Am J Med 72(5): 799-819
50. Dinarello C, Arend W, Sims J, Smith D, Blumberg H et al (2010) IL-1 family nomenclature. Nat Immunol 11(11):973
51. Dittel BN, LeBien TW (1995) The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol 154:58-67
52. Dong C (2008) Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8(5):337-348
53. Dumonde DC (1986) Work of the Lymphokine Standardization Subcommittee of the International Union of Immunological Societies. Lymphokine Res 5(Suppl 1):S1-S5
54. Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) “Lymphokines”: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224(5214):38-42
55. Dumoutier L, Renauld J (2002) Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw 13:5-15
56. Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5 flanking sequence. Immunogenetics 46:120-128
57. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ et al (2002) IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9 and IL-13. Immunity 17:7-17
58. Fan X, Sibalic V, Niederer E, Wüthrich RP (1996) The proinflammatory cytokine interleukin-12 occurs as a cell membrane-bound form on macrophages. Biochem Biophys Res Commun 225(3):1063-1067
59. Fernandez E, Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42:469-499
60. Feuerer M, Hill JA, Mathis D, Benoist C (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689-695
61. Frankenstein Z, Alon U, Cohen IR (2006) The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct 1:32. doi:10.1186/1745-6150-1-32
62. Gadina M, Hilton D, Johnston JA, Morinobu A, Lighvani A et al (2001) Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 13(3):363-373
63. Gaffen SL, Liu KD (2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28(3):109-123
64. Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM et al (1991) Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 17(2):207-214
65. Glauser MP (1997) Cytokines in severe infections: from pathophysiology to clinical applications. Eur Cytokine Netw 8(3):317-318
66. Gonda TJ, D’Andrea RJ (1997) Activating mutations in cytokine receptors: implications for receptor function and role in disease. Blood 89(2):355-369
67. Goriely S, Neurath M, Goldman M (2008) How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8:81-86
68. Gray PW, Goeddel DV (1982) Structure of the human immune interferon gene. Nature 298(5877):859-863
69. Gresser I (2007) Interferon: an unfolding tale. J Interferon Cytokine Res 27(6):447-452
70. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
71. Hamza T, Barnett JB, Li B (2010) Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 11:789-806
72. Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ (2004) Characterization of the type I interferon locus and identification of novel genes. Genomics 84:331-345
73. Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol 6(11):1123-1132
74. Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115(1):1-20
75. Henney CS, Gaffney J, Bloom BR (1974) On the relation of products of activated lymphocytes to cell-mediated cytolysis. J Exp Med 140(3):837-852
76. Huising MO, Stet RJ, Savelkoul HF, Verburg-van Kemenade BM (2004) The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28(5): 395-413
77. Huising MO, Kruiswijk CP, Flik G (2006) Phylogeny and evolution of class-I helical cytokines. J Endocrinol 189:1-25
78. Ihle JN (1995) Cytokine receptor signalling. Nature 377(6550):591-594
79. Irwin MR (2008) Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun 22(2):129-139
80. Isaacs A, Lindermann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258-267
81. Ishihara K, Hirano T (2003) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13(4-5):357-368
82. Izuhara K, Arima K, Yasunaga S (2003) IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Targets Inflamm Allergy 1(3): 263-269
83. Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78(3):183-205
84. Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175(6):3463-3468
85. Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med 354(19):2034-2045
86. Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8(Suppl2):2-14
87. Kishimoto T (2010) IL-6: from its discovery to clinical applications. Int Immunol 22(5):347-352
88. Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254
89. Kostyal DA, Beezhold DH, Hall RE (1991) Differentiation-inducing cytokine P48 exists in a membrane-associated form. J Immunol 147(3):893-898
90. Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR (2009) Molecular pathology of the fibroblast growth factor family. Hum Mutat 30(9):1245-1255
91. Kwon B, Kim BS, Cho HR, Park JE, Kwon BS (2003) Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35(1):8-16
92. Lata S, Raghava GPS (2008) CytoPred: a server for prediction and classification of cytokines. Prot Engin, Design Select 21(4):279-282
93. Lebel-Binay S, Berger A, Zinzindohoué F, Cugnenc P-H, Thiounn N et al (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11(1):15-26
94. Lee JS, Campbell HD, Kozak CA, Young IG (1989) The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome 11. Somat Cell Mol Genet 15(2):143-152
95. Leonard WJ, Lin JX (2000) Cytokine receptor signaling pathways. J Allergy Clin Immunol 105(5):877-888
96. Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA et al (2009) Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 17(10):1398-1410
97. Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275-306
98. Lodolce JP, Burkett PR, Koka RM et al (2003) Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev 13(6):429-439
99. Luster AD (1998) Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
100. Malek T, Bayer A (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4:665-674
101. Mariathasan S, Newton K, Monack D, Vucic D, French D et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430(6996):213-218
102. Martinez-Moczygemba M, Huston DP (2003) Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 112(4):653-665
103. Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190
104. Moroz A, Eppolito C, Li Q et al (2004) IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173:900-909
105. Morris CF, Young IG, Hapel AJ (1990) Molecular and cellular biology of interleukin-3. Immunol Ser 49:177-214
106. Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14:155-174
107. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128
108. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of cytokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
109. Murdoch C, Finn A (2000) Chemokine receptors and the role in inflammation and infectious disease. J Am Soc Hematol 95(10):3032-3043
110. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944
111. Musso T, Colosso L, Zucca M et al (1999) Human monocytes constitutively express membranebound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 93: 3531-3539
112. Naismith JH, Sprang SR (1996) Tumor necrosis factor receptor superfamily. J Inflamm 47(1-2): 1-7
113. Nemunaitis J (1997) A comparative review of colony-stimulating factors. Drugs 54(5):709-729
114. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP et al (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021-3029
115. Nishimoto N (2006) Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18(3): 277-281
116. Novelli F, Casanova J-L (2004) The role of IL-12, IL-23 and IFN-γ in immunity to viruses. Cytokine Growth Factor Rev 15:367-377
117. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA (2000) The Online Cytokine Reference Database. http://apresslp.gvpi.net/apcyto/lpext.dll?f=templates&fn=mainh.htm&2.0
118. O’Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC (2007) Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 44(10):2497-2506
119. Ozaki K, Leonard WJ (2002) Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277(33):29355-29358
120. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 97(21):11439-11444
121. Parrish-Novak J, Dillon S, Nelson A et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57-63
122. Paul WE, Kishimoto T, Melchers E et al (1992) Nomenclature for secreted regulatory proteins of the immune system (interleukins). WHO-IUIS Nomenclature Subcommittee on Interleukin Designation. Clin Exp Immunol 88:367
123. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929-979
124. Proulx F, Joyal JS, Mariscalco MM, Leteurtre S, Leclerc F, Lacroix J (2009) The pediatric multiple organ dysfunction syndrome. Ped Crit Care Med 10(1):2-22
125. Puri RK (1995) Structure and function of interleukin-4 and its receptor. Cancer Treat Res 80:143-185
126. Ransohoff RM, Liu L, Cardona AE (2007) Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 82:187-204
127. Rouveix B (1997) Clinical pharmacology of cytokines. Eur Cytokine Netw 8(3):291-293
128. Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A et al (2004) Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 103: 407-412
129. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479-490
130. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163-189
131. Schultz U, Kaspers B, Staeheli P (2004) The interferon system of non-mammalian vertebrates. Dev Comp Immunol 28:499-508
132. Schuster B, Kovaleva M, Sun Y, Regenhard P, Matthews V et al (2003) Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem (US) 278(11):9528-9535
133. Schwantner A, Dingley AJ, Ozbek S, Rose-John S, Grötzinger J (2004) Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy. J Biol Chem (US) 279(1):571-576
134. Sen GC (2001) Viruses and interferons. Ann Rev Microbiol 55:255-281
135. Shortman K, Naik SH (2007) Steady-stat and inflammatory dendritic-cell development. Nat Rev Immunol 7(1):19-30
136. Simon D, Braathen L, Simon H (2004) Eosinophils and atopic dermatitis. Allergy 59:561-570
137. Sims J, Nicklin M, Bazan J et al (2001) A new nomenclature for IL-1-family genes. Trends Immunol 22:536-537
138. Smallwood PM, Munozsanjuan I, Tong P, Macle JP, Hendry SHC et al (1996) Fibroblast growth factor (FGF) homologous factors - new members of the FGF family implicated in nervous-system development. Proc Natl Acad Sci USA 93(18):9850-9857
139. Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240(4856):1169-1176
140. Smith K (2001) Interleukin 2 immunotherapy. In: Austen F, Burakoff S, Rosen F, Strom T (eds) Therapeutic immunology, 2nd edn. Blackwell Science, Malden, MA, pp 240-250
141. Smith KA (2006) The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs. Med Immunol 5(3):1-5
142. So T, Lee SW, Croft M (2006) Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 83(1):1-11
143. Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19(3):281-286
144. Taga T, Kishimoto T (1992) Cytokine receptors and signal transduction. FASEB J 6:3387-3396
145. Tang P, Hung MC, Klostergaard J (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35(25):8216-8225
146. Tavernier J, Cornelis S, Devos R, Guisez Y, Plaetinck G, Van der Heyden J (1995) Structure/function analysis of human interleukin 5 and its receptor. Agents Actions Suppl 46:23-34
147. Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87-113
148. The Cytokines Web. http://cmbi.bjmu.edu.cn/cmbidata/cgf/CGF_Database/cytweb/targets/index.html
149. Thomson AW, Lotze MT (2003) The cytokine handbook, 4th edn. Academic, Amsterdam
150. Throm MJ (2008) A review of the pharmacology and pharmacotherapy of colony-stimulating factors. J Infus Nurs 31(5):295-306
151. Tieri P, Valensin S, Latora V, Castellani GC, Marchiori M et al (2005) Quantifying the relevance of different mediators in the human immune cell network. Bioinformatics 21:1639-1643
152. Tominaga A, Takaki S, Hitoshi Y, Takatsu K (1992) Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines. Bioessays 14(8): 527-533
153. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J et al (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177(1):36-39
154. Tracey K (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289-296
155. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133-146
156. Tuck DP, Cerretti DP, Hand A, Guha A, Sorba S, Dainiak N (1994) Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 84:2182-2188
157. Uzé G, Schreiber G, Piehler J, Pellegrini S (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316:71-95
158. Vgontzas AN, Bixler EO, Lin HM et al (2005) IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12(3):131-140
159. Vilcek J (2003) Novel interferons. Nat Immunol 4:8-9
160. Vilcek J (2007) My fifty years with interferon. J Interferon Cytokine Res 27(7):535-542
161. Waldmann TA (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immun 6(8):595-601
162. Walz A, Peveri P, Aschauer H et al (1987) Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149:755-761
163. Ward PA, Remold HG, David JR (1969) Leukotactic factor produced by sensitized lymphocytes. Science 163(871):1079-1081
164. Wills-Karp M (2000) The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res 1:19-23
165. Wilson KP, Black JA, Thomson JA et al (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370:270-273
166. Yasukawa M, Yakushijin Y, Hasegawa H, Miyake M, Hitsumoto Y et al (1993) Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones. Blood 81:1527-1534
167. Yoshimura T, Matsuhima K, Tanaka S et al (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defence cytokines. Proc Natl Acad Sci USA 94:9233-9237
168. Yu J, Gaffen S (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13:170-177
169. Zdanov A, Schalkhini C, Wlodawer A (1996) Crystal-structure of human interleukin-10 at 1.6 angstrom resolution and a model of a complex with its soluble receptor. Prot Sci 5(10):1955-1962
170. Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE et al (2005) Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201:139-148
171. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121-127
172. Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243